Hormones: The New Emotional Health Paradigm

Hormones: The New Emotional Health Paradigm

Most of the time when we think of the benefits of hormones, we think of them in terms of sexual health or as a remedy for what ails the menopausal woman. However, one of the most potent effects of hormonal therapy reaches deep into the psyche and proves that hormone replacement may have extensive benefits far beyond the reach and scope of what hormones have originally been used for.

 

 

First, What Are Hormones:

Transported through our blood, hormones are our body’s signalers and stimulate specific cells or tissues into action. Hormones are responsible for such critical processes as growth and development, metabolism, sexual function, reproduction, and mood. They are vital to your overall health and well-being and once they decline or become imbalanced, these vital processes also decline or become imbalanced, which can lead to issues like weight gain, bone loss, cardiovascular disease, diabetes, thyroid disorders, and reproductive challenges.

Emotional Health:

The importance of emotional health cannot for one minute be understated and although the medical community stresses it’s importance, it often gets placed last on the list of people’s health initiatives. This may be because the concept of mental and social well-being is less defined than that of physical well-being. On top of this ambiguity, there is a stigma associated to admitting a need for and seeking out emotional health. This is unfortunate since emotional health is an integral part of our whole-body health. Research has repeatedly shown that emotional distress creates susceptibility for physical illness. Stress increases vulnerability to viral infection and workplace and everyday stress can create susceptibility to cardiovascular disease. Meaning, you cannot have physical health without emotional health.

As we get older, these mounting external stresses combined with dramatic changes in the body, can put a huge strain on our mental and emotional health. Research is showing more and more that hormonal declines are critical catalysts to this common decrease in feelings of well-being, as well as an increase in stress-related illnesses.

Estrogen, Progesterone, and Mood: There is a common stereotype that pre-menopausal and menopausal women are “moody.” This label, albeit true, often gives doctors and women an excuse to chalk up their depression and anxiety as another bothersome “symptom” of menopause. In truth, this symptom is a bright, blinking warning sign that a woman is experiencing a drop in her important hormone levels, which is not just impacting her mood, but many other aspects of her health also.

Estrogen and progesterone play an important regulatory role in a woman’s overall sense of well-being. The risk of depression doubles or even quadruples during the menopausal transition. During this time, when estradiol and progesterone quickly decline, many women develop symptoms of depression, anxiety, and mood swings.

Estrogen plays an important role in the brain where it exerts neuroprotective actions. Its loss during aging and natural or surgical menopause is associated with mitochondrial dysfunction, neuroinflammation, synaptic decline, cognitive impairment and increased risk of age-related disorders. This loss can be detected early on in cognitive and behavioral indicators, such as foggy thinking and depression and anxiety. Estrogen’s effect on mood is primarily due to its role in increasing serotonin and beta-endorphins which are associated with positive mood states, as well as acetylcholine, a memory neurotransmitter.

Like estrogen, progesterone receptors are also expressed throughout the brain and can be found in every type of brain cell. Progesterone is thought to promote emotional health by boosting serotonin and GABA, which both work to decrease irritability, calm anxiety, and promote a healthy sleep cycle. Also, a progesterone metabolite, allopregnanolone, is believed to be involved in regulating mood and anxiety. The research on this metabolite is early but indicates an antidepressant and anti-anxiety effect in the body.

Testosterone and Mood: In men, low levels of testosterone cause significant mood swings. A 2016 study on older men found that “low serum testosterone was associated with an 86% increased hazard of depression.” In fact, even borderline testosterone levels are associated with significantly higher rates of depression and/or depressive symptoms.  Supplementing testosterone has been shown to be an effective treatment. A 2019 review and meta-analysis of 27 randomized controlled trials found that “testosterone treatment appears to be effective and efficacious in reducing depressive symptoms in men.”

Thyroid and Mood: Thyroid deficiency inhibits the brain’s neurotransmitters, potentially leading to depression and mental fogginess. Thyroid hormones also influence blood glucose levels and the release of stress hormones, which also contributes to mood fluctuation. Hypothyroid patients usually meet several criteria for depression—such as concentration difficulties, lassitude, low libido, and sometimes pessimism or sadness.

Research shows that thyroid supplementation in both clinical hypothyroid and subclinical thyroid levels improve these feelings of depression. In a study, women with mild hypothyroidism who screened negative for a psychiatric syndrome, showed statistically significant mood improvement and improved verbal fluency after 6 months of therapy.

DHEA and Mood: DHEA and DHEA(S) are the most abundant circulating steroid in humans. Biological actions of DHEA(S) in the brain involve neuroprotection, neurite growth, neurogenesis and neuronal survival, as well as antioxidant, anti-inflammatory and anti-glucocorticoid effects. In addition, DHEA affects endorphin synthesis/release. In three double-blind, placebo-controlled studies of DHEA, administration in major depressive disorders, patients reported a significant reduction in depressive symptomatology.

It’s crystal clear, through research and patient feedback, that optimal levels of hormones are crucial to psychological health. What isn’t clear is why imbalances or suboptimal levels are often ignored by the medical community as common symptoms of the aging process. Often, people with suboptimal levels of hormones are put on anti-depressants, which may help depressive symptoms short-term but leave the ultimate source untreated.

Emotional well-being is paramount to mental and physical health and hormones are foundational to emotional well-being. Research and patient testimonials continue to illustrate this causative and crucial link.

How Can I Find a Doctor Who Prescribes Bio-Identical Hormones for Emotional Well-Being?

The Academy of Preventive and Innovative Medicine trains physicians in hormone therapy.  We have not only identified competent and forward-thinking physicians throughout the country who offer these therapies, most of them are also trained by our experts to offer you the best care. To find a doctor near you, simply go to www.worldlinkmedical.com and click on ‘find a provider’.

 

Sources:

Cohen S, Tyrrell DAJ, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991;325:606–612.

Marmot M, Davey Smith G, Stansfield S, Patel C, North F, Head J, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet. 1991;337:1387–1393.

Rosengren A, Orth-Gomer K, Wedel H, Wilhelmsen L. Stressful life events, social support and mortality in men born in 1933. BMJ. 1993;307:1102–1105.

Kalita K, Szymczak S. Receptory estrogenowe w mózgu [Estrogen receptors in the brain]. Neurol Neurochir Pol. 2003;37 Suppl 3:63-78.

Schmidt PJ, Ben Dor R, Martinez PE, et al. Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2015;72(7):714–726. doi:10.1001/jamapsychiatry.2015.0111

Gleason CE, Dowling NM, Wharton W, et al. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med. 2015;12(6):e1001833.

Wharton W, Gleason CE, Olson SR, Carlsson CM, Asthana S. Neurobiological Underpinnings of the Estrogen – Mood RelationshipCurr Psychiatry Rev. 2012;8(3):247-256.

Celec P, Ostatníková D, Hodosy J. On the effects of testosterone on brain behavioral functions. Front Neurosci. 2015;9:12. Published 2015 Feb 17. doi:10.3389/fnins.2015.00012

Christopher J. Westley, Richard L. Amdur, Michael S. Irwig,

High Rates of Depression and Depressive Symptoms among Men Referred for Borderline Testosterone Levels. The Journal of Sexual Medicine. 2015; 12 (8): 1753-1760.

Andrew H. Ford, Bu B. Yeap, Leon Flicker, Graeme J. Hankey, S.A. Paul Chubb, David J. Handelsman, Jonathan Golledge, Osvaldo P. Almeida. Prospective longitudinal study of testosterone and incident depression in older men: The Health In Men Study. Psychoneuroendocrinology, 2016;64: 57-65.

Walther A, Breidenstein J, Miller R. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019;76(1):31–40.

  1. Gunnarsson T, Sjoberg S, Eriksson M, Nordin C. Depressive symptoms in hyothyroid disorder with some observations on biochemical correlates. Neuropsychobiology2001;43:70-4.

Bono G, Fancellu R, Blandini F, Santor G, Mauri M. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 2004;110:59-66

Pluchino N, Drakopoulos P, Bianchi-Demicheli F, Wenger JM, Petignat P, Genazzani AR. Neurobiology of DHEA and effects on sexuality, mood and cognition. J Steroid Biochem Mol Biol. 2015;145:273-280.

Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR. Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry. 1999;45:1533–1541.

Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St, Clair LS, et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005;62:154–162.

Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999;156:646–649.

Leave a Reply

Your email address will not be published. Required fields are marked *